Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0· v2Sign in
← Cases

MAP2K2

RBC: MEK2 · Substrate: ERK(K52R) ·

Top inhibitors

MeasuredDerived
DrugInhibition %Gini
Vemurafenib98.10.60
Bosutinib95.40.55
Neratinib93.20.60
Trametinib93.10.72
Gilteritinib91.70.51
Zanubrutinib89.90.79
Pirtobrutinib89.30.66
Sunitinib88.50.52
Cabozantinib78.40.75
Tivozanib74.50.67
Ripretinib66.00.67
Cobimetinib59.80.64
Ceritinib53.00.62
Ibrutinib49.20.72
Canertinib47.30.67

Known variants

No variants catalogued.
Open in new tab